Solid Biosciences is trading 9% down at $9.00 in pre-market after closing at $9.89 on August 25, 2026; no clear catalyst was identified for August 26.
- The latest company disclosure was its August 6 second-quarter report.
- Its investor-relations page shows no newer release through August 24; broader futures were mixed.
- No new company-specific announcement, earnings release, regulatory update, or analyst action was identified for August 26.